Serum Auto-Antibodies in Neurological Diseases

Enrolling by invitationOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

March 31, 2031

Study Completion Date

March 31, 2031

Conditions
Multiple SclerosisMyasthenia GravisTransverse Myelitis
Interventions
OTHER

Blood Draw

A 5cc sample of serum will be drawn from each subject. Only one blood draw is required, but up to 8 additional blood draws can be obtained.

OTHER

Cheek swab

A swab will be swished around the inside of the mouth to collect mouth (buccal) cells. This will be done with each blood draw.

Trial Locations (1)

95817

University of California, Davis, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT00704626 - Serum Auto-Antibodies in Neurological Diseases | Biotech Hunter | Biotech Hunter